Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from FDA

The Online Freakout Over Yesterday's Supreme Court Decisions

Plus: Abortion and free speech, Juul fights back, and more...

Reason

Eton Pharma Shares Tick Higher After Offloading Hospital Products

Eton Pharmaceuticals Inc (NASDAQ:ETON) has sold its hospital products to Dr. Reddy's Laboratories SA, a subsidiary of Dr. Reddy's Laboratories Ltd (NYSE:RDY), for $50 million. "The sale of our hospital products allows us to focus our resources on our core rare disease business, which is rapidly growing, and also provides an attractive opportunity to monetize…

Benzinga

The Daily Biotech Pulse: European Backing For Novavax's COVID-19 Shot In Adolescents, Sanofi-GSK's Updated Vaccine Effective Against Omicron, FDA's Clinical Hold On Sarepta's Duchenne Trial

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Juul decision triggers broader tobacco fight

FDA's Juul ban could trigger grinding fight over smoking rules

Axios

These machines to help people breathe were recalled a year ago. Many still use them

In Rochester, New York, Diane Coleman has relied on a machine to help her stay alive, but she worries that it might be slowly undermining her health.

Los Angeles Times

Sarepta Therapeutics' Shares Plummet Following FDA's Clinical Hold On MOMENTUM Study

The U.S. Food and Drug Administration (FDA) has placed a clinical hold on SRP-5051 (vesleteplirsen), Sarepta Therapeutics' (NASDAQ: SRPT) lead candidate to treat patients with Duchenne muscular dystrophy.

Benzinga

FDA Gives Approval For Novartis' Tafinlar + Mekinist Broadens BRAF/MEK Cancer Combo Use

The FDA granted accelerated approval to Novartis AG's (NYSE:NVS) pairing of Tafinlar and Mekinist for any advanced solid tumors with the BRAF V600E mutation. The patient must have progressed following prior therapy and have no alternative treatment options. The combo is already approved for BRAF mutated non-small cell lung cancer, melanoma, and thyroid cancer.…

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Sean Hannity challenges FDA to ‘arrest’ him in tantrum over Juul vape bans

Mr Hannity said he would vape live on air if the FDA banned the products

The Independent UK

FDA orders JUUL to remove all vaping products from the market

WASHINGTON — The Food and Drug Administration on Thursday ordered vaping giant JUUL to remove its remaining products from the market, after roughly two years of reviewing the company’s applications.

Tribune News Service

US federal health agency bans Juul e-cigarettes

US government bans sale and distribution of Juul products amid concerns about increase in number of teenagers vaping.

Al Jazeera

Jif peanut butter recalls continue

A West Virginia-based candy maker joins a list of companies who have also pulled Jif products from their shelves

Salon

44 Stocks Moving In Thursday's Mid-Day Session: F-star Therapeutics, Revlon And More

Gainers Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ: BHAT) rose 83.8% to $1.3824. Blue Hat Interactive terminated its previously proposed shelf takedown offering.

Benzinga

E-cigarettes: FDA bans market-leading Juul in blow to US tobacco industry

Action is part of effort by Food and Drug Administration to bring scientific scrutiny to multibillion-dollar vaping industry

The Guardian - US

Bone Health Focused Radius Health Goes Private In $890M Deal

Radius Health Inc (NASDAQ:RDUS) will be acquired by Gurnet Point Capital and Patient Square Capital in a transaction valued at approximately $890 million, including the assumption of debt and assuming full payment of the CVR (Contingent Value Right). Gurnet Point and Patient Square will pay $10.00 per share in cash plus a…

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Tucker Carlson says Biden’s nicotine crackdown will make people ‘easier to control’

The CDC says smoking is the leading cause of death in the US, accounting for 480,000 deaths each year

Benzinga

SIGA Technologies Announces $13M Worth Order For Its Monkeypox Treatment

SIGA Technologies Inc (NASDAQ:SIGA) has announced approximately $13 million in procurement orders for oral TPOXX (tecovirimat) The order includes $11 million for initial procaurement from two new international jurisdictions and an approximate $2 million order from a country in the Asia Pacific region with an established contract for oral TPOXX. "We expect a…

Input

FDA bans Juul e-cigs, parents everywhere rejoice

The Food and Drug Administration is planning to make an example out of Juul, but e-cig enthusiasts don't need to panic just yet.

The Independent UK

FDA bans Juul e-cigarettes tied to teen vaping surge

Health officials have ordered vaping company Juul to pull its electronic cigarettes from the U.S. market

Get all your
news in one place.

100's of premium titles.
One news app.

WEKU

The FDA orders Juul to pull all of its vaping products from the U.S. market

The company "will finally be held accountable for creating the youth vaping epidemic," the advocacy group Parents Against Vaping e-cigarettes told NPR. Juul said it plans to fight the decision.

Axios

FDA orders Juul e-cigarettes off U.S. market

In 2021, FDA removed thousands of electronic cigarettes off U.S. shelves but delayed its decision on Juul.

Benzinga

The Daily Biotech Pulse: F-Star Therapeutics Buyout, Orphan Drug Tag For VBI's Brain Cancer Vaccine, Xenon's Epilepsy Candidate Shows Promise

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

Congress Urges USDA & FDA To Resolve 'Hot' Hemp Difficulties, Addresses CBD Advertising, Veterans & Cannabis Research, Psychedelics

Congressional lawmakers updated several spending bills and reports dealing with important issues in the cannabis and hemp industries. New documents published by the House Appropriations Committee address hemp manu

StockNews.com

LLY's New Drug Lineup Looks Promising For Investors

Eli Lilly and Company’s (LLY) new drug line-up is expected to generate higher revenues and earnings. Also, LLY’s robust earnings, favorable analyst estimates, and higher-than-industry profitability make it a promising investment option. Read on….

Roll Call

FDA orders Juul to remove all vaping products from the market - Roll Call

The company had submitted four tobacco and menthol-flavored products for FDA authorization, but the decision could face legal challenges.

Benzinga

Benzinga Before The Bell: Tesla's Cybertruck Update, Twitter's New Feature, Netflix's Ad-Tier And Other Top Financial Stories Thursday, June 23

CNBC Pilot Shortage Pushes American Airlines To Quit Services In 4 Cities

1 … 221 222 223 224

People

Dipanjan BanchurSince

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations